Диссертация (1174185), страница 39
Текст из файла (страница 39)
Res. 2006. V.47. Issue 5. P.990-996.238.Elovainio M., Puttonen S., Heponiemi T., Reuter M., Kivimaki M., ViikariJ., Keltikangas-Jarvinen L. Relationship between DRD4 polymorphism and lipidmetabolism: what is the role of novelty seeking? // Neuropsychobiology. – 2005. V.51.
Issue 1. P.53-58.239.Elphinstone M.S., Baverstock P.R. Detecting mitochondrial genotypes bytemperaturegradientgelelectrophoresisandheteroduplexanalysis.//BioTechniques. 1997. V.23. P.982-986.240.Engel D., Beckers L., Wijnands E., Seijkens T., Lievens D., Drechsler M.,Gerdes N., Soehnlein O., Daemen M.J., Stan R.V., Biessen E.A., Lutgens E.Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influxinto the arterial wall and generating a regulatory T-cell response.
// FASEB J. 2011. V.25. Issue 11. P.3838-3848.241.Enquobahrie D.A., Rice K., Williams O.D., Williams M.A., Gross M.D.,Lewis C.E., Schwartz S.M., Siscovick D.S. IL1B genetic variation and plasma Creactive protein level among young adults: the CARDIA study. // Atherosclerosis.– 2009. V.202. Issue 2. P.513-520.242.Erbay E., Babaev V.R., Mayers J.R., Makowski L., Charles K.N., SnitowM.E., Fazio S., Wiest M.M., Watkins S.M., Linton M.F., Hotamisligil G..S.Reducing endoplasmic reticulum stress through a macrophage lipid chaperonealleviates atherosclerosis.
// Nat. Med. – 2009. V.15. Issue 12. P.1383-1391.243. Evans D., Bode A., von der Lippe G., Beil F.U., Mann W.A. Cerebrovascularatherosclerosis in type III hyperlipidemia is modulated by variation in theapolipoprotein A5 gene. // Eur. J. Med. Res. 2011. V.16. Issue 2. P.79-84.244. European cardiovascular disease statistics, 2012 edition. // European HeartNetwork and European Society of Cardiology. – 2012. – 127 p.245.Fabricant C.G., Fabricant J., Minick C.R., Literna M.M.
Herpes virusinduced atherosclerosis in chicken. // Fed. Proc. – 1983. Vol.42. P.24672469.303246.Fadini G.P., Coracina A., Baesso I., Agostini C., Tiengo A., Avogaro A., deKreutzenberg S.V. Peripheral blood CD34+KDR+ endothelial progenitor cells aredeterminants of subclinical atherosclerosis in a middle-aged general population. //Stroke.
– 2006. V.37. Issue 9. P.2277-2282.247. Faggiotto A., Ross R. Studies of hypercholesterolemia in the nonhumanprimate. II. Fatty streak conversion to fibrous plaque. // Arteriosclerosis. – 1984. V.4. – P.341-356.248.Feng X., Pu W., Gao D. Diagnostic and differential diagnostic potential ofmitochondrial DNA assessment in patients with Leber's hereditary opticneuropathy. // Zhonghua. Yan. Ke. Za.
Zhi. 2001. V.37. Issue 3. P.174177.249.Fernández-Hernando C., Yu J., Suárez Y., Rahner C., Dávalos A.,Lasunción M.A., Sessa W.C. Genetic evidence supporting a critical role ofendothelial caveolin-1 during the progression of atherosclerosis. // Cell. Metab. 2009. V.10. Issue 1. P.48-54.250.Fingert J.H., Grassi M.A., Janutka J.C., East J.S., Howard J.G., SheffieldV.C., Jacobson D.M., Hayreh S.S., Stone E.M.
Mitochondrial variant G4132A isassociated with familial non-arteritic anterior ischemic optic neuropathy in onelarge pedigree. // Ophthalmic. Genet. 2007. V.28. Issue 1. P.1-7.251.Finsterer J. Is atherosclerosis a mitochondrial disorder? // Vasa. – 2007.
V.36. Issue 4. P.229-240.252.Fu K., Hartlen R., Johns T., Genge A., Karpati G., Shoubridge E.A. A novelheteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient withmitochondrial encephalomyopathy segregates rapidly in skeletal muscle andsuggests an approach to therapy. // Hum. Mol. Genet.
– 1996. V.5. Issue 11. P.1835-1840.253.Fujiwara T., Chiba S. Alterations of vascular alpha 1-adrenergic contractileresponses in hypercholesterolemic rabbit common carotid arteries. // J.Cardiovasc. Pharmacol. – 1993. V.22. Issue 1. P.58-64.304254. Galle J., Heermeier K. Angiotensin II and oxidized LDL: an unholy alliancecreating oxidative stress. // Nephrol.
Dial. Transplant. – 1999. V.14. – P.25852589.255.García-Bermúdez M., González-Juanatey C., Rodríguez-Rodríguez L.,Vazquez-Rodriguez T.R., Miranda-Filloy J.A., Fernández-Gutierrez B., Llorca J.,Martin J., González-Gay M.A. Lack of association between LEP rs2167270 (19G>A) polymorphism and disease susceptibility and cardiovascular disease inpatients with rheumatoid arthritis. // Clin.
Exp. Rheumatol. – 2011. V.29. Issue 2. P.293-298.256.Gardener H., Beecham A., Cabral D., Yanuck D., Slifer S., Wang L.,Blanton S.H., Sacco R.L., Juo S.H., Rundek T. Carotid plaque and candidategenes related to inflammation and endothelial function in Hispanics from northernManhattan. // Stroke. – 2011. V.42. Issue 4. P.889-896.257.Gattermann N., Wulfert M., Junge B., Germing U., Haas R., Hofhaus G.Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A)in a patient with myelodysplastic syndrome. // Blood. – 2004.
V.103. Issue 4. P.1499-1502.258.Gaukrodger N., Mayosi B.M., Imrie H., Avery P., Baker M., Connell J.M.,Watkins H., Farrall M., Keavney B. A rare variant of the leptin gene has largeeffects on blood pressure and carotid intima-medial thickness: a study of 1428individuals in 248 families. // J. Med. Genet.
– 2005. V.42. Issue 6. P.474478.259.Gauvreau D., Villeneuve N., Deshaies Y., Cianflone K. Novel adipokines:links between obesity and atherosclerosis. //Ann. Endocrinol. (Paris). – 2011. –V.72. Issue 3. P.224-231.260. Geer J.C., Catsulis C., McGill H.C Jr., Stron J.P. Fine structure of the baboonaortic fatty streak. // Am. J. Pathol. – 1968. V.52.
– P.265-286.261. Geer J.C., Haust M.D. Smooth muscle cells in atherosclerosis. // Basel. Karger,1972.305262.Geerts C.C., Bots M.L., Grobbee D.E., Uiterwaal C.S. Parental smoking andvascular damage in young adult offspring: is early life exposure critical? Theatherosclerosis risk in young adults study. // Arterioscler.
Thromb. Vasc. Biol. –2008. V.28. Issue 12. P.2296-2302.263.George S.J., Williams A., Newby A.C. An essential role for platelet-derivedgrowth factor in neointima formation in human saphenous vein in vitro. //Atherosclerosis. 1996. V.120. Issue 1-2. P.227-240.264. Gerrity R.G. The role of the monocyte in atherogenesis: II.
Migration of foamcells from atherosclerotic lesions. // Am. J. Pathol. – 1981. V.103. – P.191-200.265. Gerrity R.G. The role of the monocyte in atherogenesis: I. Transition of bloodborne monocytes into foam cells in fatty lesions. // Am. J. Pathol. – 1981. V.103. – P.181-190.266.Giaginis C., Klonaris C., Katsargyris A., Kouraklis G., Spiliopoulou C.,Theocharis S..
Correlation of Peroxisome Proliferator-Activated Receptor-gamma(PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression withclinical risk factors in patients with advanced carotid atherosclerosis. // Med. Sci.Monit. 2011. V.17. Issue 7. P.381-391.267.Gil Borlado M.C., Moreno Lastres D., Gonzalez Hoyuela M., Moran M.,Blazquez A., Pello R., Marin Buera L., Gabaldon T., Garcia Peñas J.J., MartínM.A., Arenas J., Ugalde C. Impact of the mitochondrial genetic background incomplex III deficiency.
// PLoS One. – 2010. V.5. Issue 9. e12801.268.Gilardini L., Pasqualinotto L., Di Matteo S., Caffetto K., Croci M., GirolaA., Invitti C. Factors associated with early atherosclerosis and arterialcalcifications in young subjects with a benign phenotype of obesity. // Obesity.(Silver Spring). 2011. V.19. Issue 8. P.1684-1689.269.Giordano C., Pallotti F., Walker W.F., Checcarelli N., Musumeci O.,Santorelli F., d'Amati G., Schon E.A., DiMauro S., Hirano M., Davidson M.M.Pathogenesis of the deafness-associated A1555G mitochondrial DNA mutation. //Biochem. Biophys.
Res. Commun. – 2002. V.293. Issue 1. P.521-529.306270. Glass C.K., Witztum J.L Atherosclerosis. The road ahead. // Cell. – 2001. V.104. – P.503-516.271. Glenn T.C. Field guide to next-generation DNA sequencers. // Mol. Ecol.Resour. 2011. Sep.; V.11. Issue 5. – P.759-769.272.Gmiński J., Drózdz M., Ulfig-Maślanka R., Najda J. Evaluation of elastinmetabolism in children from families with high risk of atherosclerosis. //Atherosclerosis. 1991.
V.91. Issue 3. P.185-189.273.Gnasso A., Motti C., Irace C., Di Gennaro I., Pujia A., Leto E., Ciamei M.,Crivaro A., Bernardini S., Federici G., Cortese C. The Arg allele in position 192of PON1 is associated with carotid atherosclerosis in subjects with elevatedHDLs. // Atherosclerosis. 2002. V.164. Issue 2. P.289-295.274. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B.,Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C.,Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J.,Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A.,Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., NicholG., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S.,Wong N.D., Woo D., Turner M.B.; American Heart Association StatisticsCommittee and Stroke Statistics Subcommittee.
Heart disease and stroke statistics- 2013 update: a report from the American Heart Association. // Circulation. –2013. V.127. Issue 1. – P.6-245.275. Goldstein J.L., Brown M.S. The low-density lipoprotein pathway and itsrelation to atherosclerosis. // Ann. Rev. Biochem. – 1997.Vol. 46. – P.897-930.276. Goldstein J.L., Brown M.S.Atherosclerosis: the low-density lipoproteinreceptor hypothesis. // Metabolism. – 1977. – V.26.
– P.1257-1275.277.Gomaraschi M, Sinagra G, Serdoz LV, Pitzorno C, Fonda M, Cattin L,Calabresi L, Franceschini G. The plasma concentration of Lpa-I:A-II particles as apredictor of the inflammatory response in patients with ST-elevation myocardialinfarction. // Atherosclerosis. – 2009. V.202. Issue 1. P.304-311.307278.Gonçalves I., Edsfeldt A., Ko N.Y., Grufman H., Berg K., Björkbacka H.,Nitulescu M., Persson A., Nilsson M., Prehn C., Adamski J., Nilsson J. Evidencesupporting a key role of Lp-PLA2-generated lysophosphatidylcholine in humanatherosclerotic plaque inflammation.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
